A Randomised Controlled Feasibility Trial of Surgery versus No Surgery as Part of Multi-Modality Treatment in Stage III-N2 Non-Small Cell Lung Cancer

被引：0

作者：

Taylor, Sally ^{[1
]}

Stanworth, Melissa ^{[1
]}

Ward, Ashleigh ^{[1
]}

Harris, Emily ^{[1
]}

Tsim, Selina ^{[2
]}

Navani, Neal ^{[3
]}

Baldwin, David ^{[4
]}

Woolhouse, Ian ^{[5
]}

Edwards, John ^{[6
]}

Grundy, Seamus ^{[7
]}

Rhodes, Sarah ^{[8
]}

Burnside, Nathan ^{[4
]}

Blackhall, Fiona ^{[1
]}

Faivre-Finn, Corinne ^{[1
]}

Yorke, Janelle ^{[1
]}

Evison, Matthew ^{[9
]}

机构：

[1] Christie NHS Fdn Trust, Manchester, Lancs, England

[2] Queen Elizabeth Univ Hosp, Glasgow, Lanark, Scotland

[3] Univ Coll London Hosp, London, England

[4] Nottingham Univ Hosp NHS Trust, Nottingham, England

[5] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England

[6] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England

[7] Salford Royal NHS Fdn Trust, Salford, Lancs, England

[8] Univ Manchester, Manchester, Lancs, England

[9] Manchester Univ NHS Fdn Trust, Manchester, Lancs, England

来源：

LUNG CANCER | 2024年 / 190卷

关键词：

D O I：

10.1016/j.lungcan.2024.107698

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

137

引用

页数：2

共 50 条

[21] Should Surgery Be Part of the Multimodality Treatment for Stage IIIB Non-Small Cell Lung Cancer
Collaud, Stephane
Provost, Bastien
Fabre, Dominique
Mussot, Sacha
Besse, Benjamin
Mercier, Olaf
Fadel, Elie
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S576 - S576
[22] Should surgery be part of the multimodality treatment for stage IIIB non-small cell lung cancer?
Collaud, Stephane
Provost, Bastien
Besse, Benjamin
Fabre, Dominique
Le Chevalier, Thierry
Mercier, Olaf
Mussot, Sacha
Fadel, Elie
JOURNAL OF SURGICAL ONCOLOGY, 2018, 117 (07) : 1570 - 1574
[23] Predictors for locoregional recurrence for clinical stage III-N2 non-small cell lung cancer with nodal downstaging after induction chemotherapy and surgery.
Steliga, Matthew
LUNG CANCER MANAGEMENT, 2013, 2 (05) : 350 - 351
[24] Validation of the IASLC Residual Tumor Classification in Patients With Stage III-N2 Non-Small Cell Lung Cancer Undergoing Neoadjuvant Chemoradiotherapy Followed By Surgery
Lee, Junghee
Lee, Jin
Hong, Yun Soo
Lee, Genehee
Kang, Danbee
Yun, Jeonghee
Jeon, Yeong Jeong
Shin, Sumin
Cho, Jong Ho
Choi, Yong Soo
Kim, Jhingook
Zo, Jae Ill
Shim, Young Mog
Guallar, Eliseo
Cho, Juhee
Kim, Hong Kwan
ANNALS OF SURGERY, 2023, 277 (06) : E1355 - E1363
[25] SURGERY BY STAGE-III NON-SMALL CELL LUNG-CANCER
STAMATIS, G
GRESCHUCHNA, D
MAASSEN, W
THORACIC AND CARDIOVASCULAR SURGEON, 1987, 35 : 55 - 56
[26] Is there a role for surgery in stage ⅢA-N2 non-small cell lung cancer?
Paul E.VAN SCHIL
Michèle DE WAELE
Jeroen M.HENDRIKS
Patrick R.LAUWERS
中国肺癌杂志, 2008, (05) : 615 - 621
[27] Predictors for locoregional recurrence for clinical stage III-N2 non-small cell lung cancer with nodal downstaging after induction chemotherapy and surgery.
Lou, Feiran
Amini, Arya
Correa, Arlene M.
Baldassarre, Randall L.
Rimner, Andreas
Roth, Jack A.
Swisher, Stephen
Huang, James
Vaporciyan, Ara A.
Lin, Steven H.
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[28] SABR Versus Surgery for Stage I Non-Small Cell Lung Cancer
Tateishi, Yudai
Takeda, Atsuya
Horita, Nobuyuki
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (02): : 574 - 574
[29] Multi-modality therapy for stage IIIa N2 non-small cell lung cancer: Does the answer lie in the components?
Spicer, Jonathan David
Shewale, Jitesh B.
Bott, Matthew Joseph
Jones, David Randolph
Vaporciyan, Ara A.
Darling, Gail Elizabeth
Swisher, Stephen
Sepesi, Boris
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[30] Upfront Surgery Versus Neoadjuvant Treatment Followed by Surgery in Pathologic N2 Non-Small Cell Lung Cancer
Kim, S. K.
Park, H. S.
Cho, K. D.
Cho, D. G.
Park, Y. H.
Yoo, J.
Kim, S. H.
Ko, J. M.
Park, E. J.
Heo, G. R.
Kim, C. H.
Shim, B. Y.
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S900 - S901

← 1 2 3 4 5 →